Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (401-410 of 529) with videos related to

Pageof 53
Sort By:
Vaccines|March 19, 2020
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 VaccineLilin Lai, Nadine Rouphael, Yongxian Xu, et al.
Vaccine|April 16, 2024
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sexJose L Martínez, Nicholas Lemus, Tsoi Ying Lai, et al.
Genome Biology and Evolution|February 5, 2019
Evidence of Austronesian Genetic Lineages in East Africa and South Arabia: Complex Dispersal from Madagascar and Southeast AsiaNicolas Brucato, Veronica Fernandes, Pradiptajati Kusuma, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Mucosal Immunology|November 17, 2016
The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionC F Kelley, C S Kraft, T Jb de Man, et al.
Vaccine|January 24, 2021
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and olderPatricia Winokur, Hana M El Sahly, Mark J Mulligan, et al.
The Journal of Infectious Diseases|February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldWendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccines|May 7, 2025
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy AdultsAngela Branche, Mark J Mulligan, Alok Maniar, et al.
Journal of Crohn'S & Colitis|January 23, 2026
Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD servicesA Barney Hawthorne, Paul Christiansen, Ian Arnott, et al.
Antiviral Therapy|August 17, 2012
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youthAllison Ross Eckard, Suzanne E Judd, Thomas R Ziegler, et al.
Pageof 53

Showing results (401-410 of 529) with videos related to

Sort By:
Pageof 53
Vaccines|March 19, 2020
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 VaccineLilin Lai, Nadine Rouphael, Yongxian Xu, et al.
Vaccine|April 16, 2024
The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sexJose L Martínez, Nicholas Lemus, Tsoi Ying Lai, et al.
Genome Biology and Evolution|February 5, 2019
Evidence of Austronesian Genetic Lineages in East Africa and South Arabia: Complex Dispersal from Madagascar and Southeast AsiaNicolas Brucato, Veronica Fernandes, Pradiptajati Kusuma, et al.
Physiological Genomics|March 15, 2012
Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesisS W Walsh, J P Mehta, P A McGettigan, et al.
Mucosal Immunology|November 17, 2016
The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionC F Kelley, C S Kraft, T Jb de Man, et al.
Vaccine|January 24, 2021
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and olderPatricia Winokur, Hana M El Sahly, Mark J Mulligan, et al.
The Journal of Infectious Diseases|February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldWendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccines|May 7, 2025
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy AdultsAngela Branche, Mark J Mulligan, Alok Maniar, et al.
Journal of Crohn'S & Colitis|January 23, 2026
Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD servicesA Barney Hawthorne, Paul Christiansen, Ian Arnott, et al.
Antiviral Therapy|August 17, 2012
Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youthAllison Ross Eckard, Suzanne E Judd, Thomas R Ziegler, et al.
Pageof 53